Aldeyra Therapeutics, Inc.
ALDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001341235
No open-market purchases or sales by Aldeyra Therapeutics, Inc. insiders were filed in the last 90 days; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Aldeyra Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- +10 vs. Q4 2024
- Shares held
- 37.9M
- +900.9K (+2.4%) vs. Q4 2024
- Total value
- $215.5M
- +$31.0M (+16.8%) vs. Q4 2024
- New holders
- 24
- 26 more added
- Sold out
- 14
- 47 more reduced
3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 107 | $77.7M |
| Q1 2026 | 128 | $63.3M |
| Q4 2025 | 136 | $201.8M |
| Q3 2025 | 131 | $204.2M |
| Q2 2025 | 122 | $130.8M |
| Q1 2025 | 126 | $215.5M |
| Q4 2024 | 119 | $185.6M |
| Q3 2024 | 112 | $196.4M |
| Q2 2024 | 103 | $116.9M |
| Q1 2024 | 101 | $115.8M |
| Q4 2023 | 105 | $123.3M |
| Q3 2023 | 120 | $252.3M |
| Q2 2023 | 119 | $327.5M |
| Q1 2023 | 109 | $353.4M |
| Q4 2022 | 96 | $237.9M |
| Q3 2022 | 89 | $197.4M |
| Q2 2022 | 95 | $147.5M |
| Q1 2022 | 111 | $171.8M |
| Q4 2021 | 115 | $146.7M |
| Q3 2021 | 117 | $348.9M |
| Q2 2021 | 136 | $512.8M |
| Q1 2021 | 108 | $376.7M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Aldeyra Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 3,434 | $19.0K | 0.00% | −3,771−52.3% | Reduced |
| Tower Research Capital LLC (TRC) | 2,199 | $12.6K | 0.00% | −2,227−50.3% | Reduced |
| Activest Wealth Management | 2,000 | $11.5K | 0.00% | 00.0% | Unchanged |
| Raffa Wealth Management, LLC | 1,897 | $10.9K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 1,630 | $9.37K | 0.00% | +49+3.1% | Added |
| Amalgamated Bank | 1,571 | $9.00K | 0.00% | 00.0% | Unchanged |
| Skopos Labs, Inc. | 1,442 | $8.29K | 0.00% | +1,442 | New |
| Stephens Consulting, LLC | 1,000 | $5.75K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 880 | $5.06K | 0.00% | +300+51.7% | Added |
| Sterling Capital Management LLC | 777 | $4.47K | 0.00% | −661−46.0% | Reduced |
| GAMMA Investing LLC | 684 | $3.93K | 0.00% | +684 | New |
| PSI Advisors, LLC | 650 | $3.74K | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 397 | $2.28K | 0.00% | +382+2,546.7% | Added |
| Truvestments Capital LLC | 265 | $1.52K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 263 | $1.51K | 0.00% | +11+4.4% | Added |
| True Wealth Design, LLC | 243 | $1.40K | 0.00% | +223+1,115.0% | Added |
| Comerica Bank | 238 | $1.37K | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 171 | $983 | 0.00% | +171 | New |
| HighMark Wealth Management LLC | 155 | $891 | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 125 | $719 | 0.00% | −57−31.3% | Reduced |
| Wolff Wiese Magana LLC | 113 | $650 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 94 | $541 | 0.00% | +60+176.5% | Added |
| Parallel Advisors, LLC | 30 | $173 | 0.00% | +30 | New |
| US Bancorp | 24 | $138 | 0.00% | +24 | New |
| TD Waterhouse Canada Inc. | 15 | $82 | 0.00% | 00.0% | Unchanged |
| Nuveen, LLC | 348,521 | – | – | +348,521 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −85,642−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −47,792−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −39,198−100.0% | Sold out |
| Tobias Financial Advisors, Inc. | 0 | $0 | 0.00% | −23,695−100.0% | Sold out |
| Laidlaw Wealth Management LLC | 0 | $0 | 0.00% | −18,175−100.0% | Sold out |
| U.S. Capital Wealth Advisors, LLC | 0 | $0 | 0.00% | −13,875−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −13,706−100.0% | Sold out |
| King Wealth | 0 | $0 | 0.00% | −13,500−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −13,100−100.0% | Sold out |
| Diversified Trust Co | 0 | $0 | 0.00% | −12,265−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −11,278−100.0% | Sold out |
| Prime Capital Investment Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −9,791−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| AlphaCentric Advisors LLC | – | – | – | – | Not filed |
| Boston Financial Mangement LLC | – | – | – | – | Not filed |